IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3

NCT03401073 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Small Fiber Neuropathy
Idiopathic Peripheral Neuropathy

Interventions

DRUG: Intravenous immunoglobulin
DRUG: 0.9% Sodium Chloride

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]